Harnessing the potential of multimodal radiotherapy in prostate cancer

Harnessing the potential of multimodal radiotherapy in prostate cancer

Radiotherapy in combination with androgen deprivation therapy (ADT) is a standard treatment option for men with localized and locally advanced prostate cancer. However, emerging clinical evidence suggests that radiotherapy can be incorporated into multimodality therapy regimens beyond ADT, in combin...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Philippou, Y, Sjoberg, H, Lamb, AD, Camilleri, P, Bryant, RJ
Format:	Journal article
Sprog:	English
Udgivet:	Springer Nature 2020

Lignende værker

Investigating tumour immune microenvironment effects of hypofractionated radiotherapy +/- immune checkpoint blockade in immunocompetent pre-clinical prostate cancer models
af: Y Philippou, et al.
Udgivet: (2020-07-01)

8 Novel enhancement of multimodality treatment of prostate cancer, combining radiotherapy,vascular-targeted photodynamic therapy, and immunotherapy
af: H.T. Sjoberg, et al.
Udgivet: (2025-01-01)

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
af: Philippou, Y, et al.
Udgivet: (2020)

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
af: Charlton, P, et al.
Udgivet: (2023)

Harnessing the power of RNA in determining the origin of lethal micro-metastatic prostate cancer
af: A.M. Erickson, et al.
Udgivet: (2020-07-01)

Re: Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study
af: Philippou, Y, et al.
Udgivet: (2020)

Investigating multi-modal therapy with radiotherapy, vascular-targeted photodynamic therapy and immunotherapy in pre-clinical models of prostate cancer
af: Philippou, Y
Udgivet: (2021)

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
af: Charlton, PV, et al.
Udgivet: (2024)

Orient expression: solving the mystery of Asian prostate cancer?
af: Lamb, A, et al.
Udgivet: (2017)

Perspectives on technology - prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy?
af: Berridge, C, et al.
Udgivet: (2024)

Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial
af: Marian, IR, et al.
Udgivet: (2024)

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
af: Wu, X, et al.
Udgivet: (2019)

Redaktören har ordet
af: Katarina Sjöberg
Udgivet: (2008-10-01)

Redaktören har ordet
af: Katarina Sjöberg
Udgivet: (2007-10-01)

Redaktören har ordet
af: Katarina Sjöberg
Udgivet: (2008-07-01)

Redaktören har ordet
af: Katarina Sjöberg
Udgivet: (2007-01-01)

Redaktören har ordet
af: Katarina Sjöberg
Udgivet: (2007-04-01)

Redaktören har ordet
af: Katarina Sjöberg
Udgivet: (2008-01-01)

Redaktören har ordet
af: Katarina Sjöberg
Udgivet: (2007-07-01)

Redaktören har ordet
af: Katarina Sjöberg
Udgivet: (2008-04-01)

The use of digital pathology and artificial intelligence in histopathological diagnostic assessment of prostate cancer: a survey of prostate cancer UK supporters
af: Rakovic, K, et al.
Udgivet: (2022)

A systematic review of prostate cancer heterogeneity: understanding the clonal ancestry of multifocal disease
af: Erickson, A, et al.
Udgivet: (2021)

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
af: Hamdy, FC, et al.
Udgivet: (2023)

Treatment of breast and prostate cancer by hypofractionated radiotherapy: potential risks and benefits
af: Ray, KJ, et al.
Udgivet: (2015)

Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer
af: Sefora Conti MSc, et al.
Udgivet: (2018-12-01)

Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits
af: Ray, K, et al.
Udgivet: (2015)

Harnessing uncertainty in radiotherapy auto-segmentation quality assurance
af: Kareem A. Wahid, et al.
Udgivet: (2024-01-01)

Updates on Radiotherapy for Localized Prostate Cancer
af: Alexandros Papachristofilou
Udgivet: (2023-12-01)

Advances in Radiotherapy for Prostate Cancer Treatment
af: Tarun Podder, et al.
Udgivet: (2016-01-01)

Editorial: Advances in radiotherapy for prostate cancer
af: Sophia C. Kamran, et al.
Udgivet: (2022-12-01)

Stereotactic Body Radiotherapy for Prostate Cancer
af: Neil R. Parikh M.D., et al.
Udgivet: (2020-06-01)

MR-Guided Radiotherapy for Prostate Cancer
af: Boris R. Tocco, et al.
Udgivet: (2020-12-01)

Multimodality functional imaging in rectal cancer treated with radiotherapy
af: Greenhalgh, T
Udgivet: (2022)

Impact of age on treatment response in men with prostate cancer treated with radiotherapy
af: Alex K. Bryant, et al.
Udgivet: (2022-05-01)

The tumor microenvironment and immune responses in prostate cancer patients
af: Kwon, JTW, et al.
Udgivet: (2021)

Diagnostic pathways for screen-detected prostate cancer: The plot thickens
af: Hamdy, F, et al.
Udgivet: (2017)

First report of prostate-specific membrane antigen-targeted immunotherapy in prostate cancer: the future is bright
af: Lamb, A, et al.
Udgivet: (2018)

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy
af: Kachris S, et al.
Udgivet: (2021-11-01)

From microbes to medicine: harnessing the gut microbiota to combat prostate cancer
af: Anjali Yadav, et al.
Udgivet: (2024-05-01)

Harnessing machine learning to predict prostate cancer survival: a review
af: Sungun Bang, et al.
Udgivet: (2025-01-01)